Skip to main content
TipRanks
Go Ultimate75% OFF

Interpace Diagnostics Group (PF4) Ownership - Who Owns Interpace Diagnostics Group?

0 Followers

Interpace Diagnostics Group (PF4) Ownership Overview

  • 90.61% Insiders
  • 9.39% Public Companies and Individual Investors

The ownership structure of Interpace Diagnostics Group (DE:PF4) stock is a mix of institutional, retail, and individual investors. , 90.61% is owned by Insiders, and 9.39% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Feb 16, 20261315 Capital Ii, L.p.$19,000,001
Feb 03, 2026Ampersand 2018 Limited Partnership$28,000,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

DE:PF4 top shareholders
Holder# of SharesType% HoldingValue
Thomas W. Burnell1,466,812Insider24.85%10,414,365
Christopher Mccarthy323,800Insider5.49%2,298,980
Stephen Sullivan24,583Insider0.42%174,539
Joseph Keegan17,569Insider0.30%124,740

FAQ

What percentage of Interpace Diagnostics Group (DE:PF4) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.39% of Interpace Diagnostics Group (DE:PF4) stock is held by public companies and individual investors.
Who owns the most shares of Interpace Diagnostics Group (DE:PF4)?
Thomas W. Burnell owns the most shares of Interpace Diagnostics Group (DE:PF4).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.